|
2022
|
Invention
|
Diagnostic indices for neurodegenerative conditions. A method to evaluate individuals with certai... |
|
|
Invention
|
Nk-1 antagonist compositions and methods for use in treating depression. The present invention de... |
|
2020
|
Invention
|
Kinases as biomarkers for neurodegenerative conditions.
An assay for using signaling kinases alo... |
|
|
Invention
|
Kinases as biomarkers for neurodegenerative conditions. An assay for using signaling kinases alon... |
|
|
Invention
|
Compositions and methods for treating synucleinopathies. The present invention describes the use ... |
|
|
Invention
|
Alpha-synuclein assays.
An assay for alpha synuclein and its various forms includes: a) providin... |
|
|
Invention
|
Alpha-synuclein assays. An assay for alpha synuclein and its various forms includes: a) providing... |
|
2019
|
Invention
|
Domperidone compositions and methods for treating depression.
The present invention describes th... |
|
|
Invention
|
Domperidone compositions and methods for treating depression. The present invention describes the... |
|
|
Invention
|
Domperidone antineurodegenerative combinations and use.
A pharmaceutical combination comprising ... |
|
|
Invention
|
Domperidone antineurodegenerative combinations and use. A pharmaceutical combination comprising d... |
|
|
Invention
|
Anti-neurodegenerative combinations and use for treatment of neurodegenerative diseases.
The pre... |
|
|
Invention
|
Anti-neurodegenerative combinations and use for treatment of neurodegenerative diseases. The pres... |
|
|
Invention
|
Composition and use for the treatment of parkinson's disease and related disorders.
The present ... |
|
|
Invention
|
Composition and use for the treatment of parkinson's disease and related disorders. The present i... |
|
2018
|
Invention
|
Methods for developing pharmaceuticals for treating neurodegenerative conditions.
Provided herei... |
|
|
Invention
|
Methods for developing pharmaceuticals for treating neurodegenerative conditions. Provided herein... |
|
|
Invention
|
Statin compositions and methods for use in treating synucleinopathies.
The present invention des... |
|
|
Invention
|
Statin compositions and methods for use in treating synucleinopathies. The present invention desc... |
|
|
Invention
|
Composition comprising pramipexole and nk1-antagonists for treating depression. The present inven... |
|
|
Invention
|
Pharmaceutical combinations of zonisamide and pramipexole, and related methods, for treating synu... |
|
|
Invention
|
Pharmaceutical combinations of zonisamide and praxipexole, and related methods, for treating synu... |
|
|
Invention
|
Compositions and method for treating depression.
The present invention describes the combination... |
|
|
Invention
|
Composition comprising pramipexole and 5ht3 antagonist for treating dep ression. The present inve... |
|
|
Invention
|
Compositions and method for treating depression. The present invention describes the combination ... |
|
|
Invention
|
Pharmaceutical combination and its use for treating synucleinopathties. The present invention des... |
|
|
Invention
|
Pharmaceutical combination comprising fluoxetine and pramipexole and its use for treating synucle... |
|
|
Invention
|
Pharmaceutical combination and its use for treating synucleinopathies. The present invention desc... |
|
|
Invention
|
Nk1-antagonist combination and method for treating synucleinopathies. The present invention descr... |
